The country has relatively few doses and is paying a price for its leader’s slow pursuit of vaccines early on. That lapse may hinder Brazil’s ability to fight worrisome variants.
Brazil says CoronaVac has an efficacy rate just over 50 percent, much lower than previously announced. More than 380 million doses have already been ordered.
Scientists have developed dozens of Covid vaccines at record speed. Here are the leading products.
El gobierno espera emprender pronto la inmunización a nivel nacional, pero la vacuna de la empresa china requiere la aprobación de los reguladores de seguridad y de un influyente consejo religioso.
Sinovac Biotech has sold more than 300 million doses to the developing world, filling a gap left by Western countries.
See how the leading vaccines train the immune system to fight the virus.
President Joko Widodo hopes to begin inoculations soon, but the vaccine from the Chinese company Sinovac still needs approval from safety regulators and an influential council of Muslim clerics.
Across the country, local governments plan to inoculate 50 million people by early next year. But the vaccines have not officially been approved.
The clinical trial in Turkey was much smaller than those of other major vaccine candidates, making the researchers’ claims for it less certain.
Luchas políticas internas, una planificación azarosa y un creciente movimiento antivacunas han convertido al país suramericano en una advertencia en la era del coronavirus.
Political infighting, haphazard planning and a rising anti-vaccine movement have turned the country into a cautionary tale in the coronavirus era.
A look at all the vaccines that have reached trials in humans.